XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT
Rentschler Biopharma SE
Application Filed: 2022-05-23
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79362259 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
Timeline
| 2022-05-23 | Application Filed |
| 2023-02-09 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2023-02-09 | Status: Live/Pending |
| 2023-02-10 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Rentschler Biopharma SE |
| Entity Statement | SE |
| Address | Erwin-Rentschler-Str. 21 88471 Laupheim DE |
| Legal Entity Type | |
| Legal Entity State | DE |
| Owner: | Vetter Pharma-Fertigung GmbH & Co. KG |
| Address | Schützenstr. 87 88212 Ravensburg DE |
| Legal Entity Type | Gmbh & Co. Kg |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260513 | Triangles, exactly two triangles; Two triangles |
| 260521 | Triangles that are completely or partially shaded |
Attorney of Record
Good, Services, and Codes
| International Codes: | 39 |
| U.S. Codes: | 100,105 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0401 | Contract manufacturing, in relation to the following goods: pharmaceuticals, pharmaceutical substances; custom manufacture of veterinary preparations and substances; custom manufacture of diagnostic preparations and substances; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; consultancy services relating to custom manufacturing services; assembly of products for others, custom manufacture and assembly services, custom assembly for others, in particular, in relation to the following goods: electronic components for medical devices and apparatus, semiconductor components and circuit switches; consultancy and information for the customised manufacture and production of electronic components, semi-conductor components and circuits for medical apparatus and equipment |
| GS0401 | Contract manufacturing in the field of pharmaceuticals and pharmaceutical substances; custom manufacture of veterinary preparations and substances; custom manufacture of diagnostic preparations and substances for medical and veterinary use; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; consultancy services relating to custom manufacturing process services; assembly of products for others, custom manufacture and assembly services, custom assembly for others of electronic components for medical devices and apparatus, semiconductor components and circuit switches; consultancy and information for the customised manufacture and production processes for electronic components, semi-conductor components and circuits for medical apparatus and equipment |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2023-02-09 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-02-10 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2023-02-14 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2023-03-11 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-03-21 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-03-22 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-05-11 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-05-12 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-06-07 | 9 RFNP P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-11-09 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-11-09 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-11-09 | 12 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2023-12-05 | 13 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2023-12-05 | 14 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2023-12-05 | 15 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2023-12-05 | 16 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-12-05 | 17 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-12-20 | 18 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2023-12-20 | 19 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-12-20 | 20 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2024-01-08 | 21 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2024-01-09 | 22 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-01-09 | 23 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2024-03-26 | 24 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-03-26 | 25 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2024-06-27 | 26 FICR P: |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 